$0.17
Thermogenesis is a medical devices business based in the US. Thermogenesis shares (THMO) are listed on the NASDAQ and all prices are listed in US Dollars. Thermogenesis employs 25 staff and has a trailing 12-month revenue of around $9.6 million.
Our top picks for where to buy Thermogenesis stock
How to buy Thermogenesis stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – THMO. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Thermogenesis stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Thermogenesis stock price (NASDAQ: THMO)
Use our graph to track the performance of THMO stocks over time.Thermogenesis shares at a glance
Latest market close | $0.16 |
---|---|
52-week range | $0.13 - $1.43 |
50-day moving average | $0.41 |
200-day moving average | $0.71 |
Wall St. target price | $5.00 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-3.98 |
Is it a good time to buy Thermogenesis stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Thermogenesis price performance over time
Historical closes compared with the close of $0.16 from 2024-07-25
1 week (2024-07-19) | 14.20% |
---|---|
1 month (2024-06-27) | -27.27% |
3 months (2024-04-26) | -76.47% |
6 months (2024-01-26) | -57.89% |
1 year (2023-07-27) | -87.88% |
---|---|
2 years (2022-07-27) | -20.00% |
3 years (2021-07-27) | 2.25 |
5 years (2019-07-26) | 2.93 |
Thermogenesis financials
Revenue TTM | $9.6 million |
---|---|
Gross profit TTM | $3.5 million |
Return on assets TTM | -25.5% |
Return on equity TTM | -801.94% |
Profit margin | -153.43% |
Book value | $0.12 |
Market Capitalization | $2.2 million |
TTM: trailing 12 months
Thermogenesis share dividends
We're not expecting Thermogenesis to pay a dividend over the next 12 months.
Have Thermogenesis's shares ever split?
Thermogenesis's shares were split on a 1:45 basis on 21 December 2022. So if you had owned 45 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Thermogenesis shares – just the quantity. However, indirectly, the new 4400% higher share price could have impacted the market appetite for Thermogenesis shares which in turn could have impacted Thermogenesis's share price.
Thermogenesis share price volatility
Over the last 12 months, Thermogenesis's shares have ranged in value from as little as $0.1251 up to $1.43. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Thermogenesis's is 2.286. This would suggest that Thermogenesis's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Thermogenesis overview
ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for cell-banking, cell-processing, and cell-based therapeutics in the United States, China, the United Arab Emirates, Vietnam, and internationally. The company provides medical device products for automated cell processing. Its clinical bio-banking applications include AXP II Automated Cell Separation System, an automated fully closed cell separation system for isolating stem and progenitor cells from umbilical cord blood; and BioArchive Automated Cryopreservation System, an automated, robotic, liquid nitrogen controlled-rate-freezing and cryogenic storage system for cord blood samples and cell therapeutic products used in clinical applications. The company's point-of-care applications include XP Point-of-Care System, an automated, fully closed, sterile system that allows for the rapid and automated processing of autologous peripheral blood or bone marrow aspirate derived stem cells at the point-of-care, such as surgical centers or clinics; and PXP-1000 System, an automated, fully closed system that provides fast, reproducible separation of multiple cellular components from blood with minimal red blood cell contamination. Its cell processing products comprise X-Series products for general laboratory use, such as X-Lab for cell isolation, X-Wash System for cell washing and reformulation, and X-Mini for high efficiency small scale cell purification. The company also provides contract development and manufacturing services for cell and cell-based gene therapies.
Frequently asked questions
What percentage of Thermogenesis is owned by insiders or institutions?Currently 28.019% of Thermogenesis shares are held by insiders and 0.715% by institutions. How many people work for Thermogenesis?
Latest data suggests 25 work at Thermogenesis. When does the fiscal year end for Thermogenesis?
Thermogenesis's fiscal year ends in December. Where is Thermogenesis based?
Thermogenesis's address is: 2711 Citrus Road, Rancho Cordova, CA, United States, 95742 What is Thermogenesis's ISIN number?
Thermogenesis's international securities identification number is: US88362L1008 What is Thermogenesis's CUSIP number?
Thermogenesis's Committee on Uniform Securities Identification Procedures number is: 883623209
More guides on Finder
-
Opto review 2024: $0 commission, fractional theme investing
Trade commission-free stocks and ETFs with Opto, and stay ahead by spotting emerging trends through thematic investing.
-
Best paper trading platforms to practice trading with fake money [2024]
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
-
Put options explained
Learn the basics of put options: what they are, how they work and a few examples.
-
Best broker cash sweep rates for July 2024
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
-
7 best day trading platforms of July 2024
These are the best day trading platforms, according to Finder’s comprehensive analysis.
-
Today’s best brokerage account bonuses [Signup and transfer promos]
Explore the best bonuses for opening a new brokerage account.
-
11 apps like Webull you need to consider
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
7 best ways to invest $10K
Check out our 7 ideas for how to invest $10K to maximize your money.
-
5 best ETFs for 2024
Check out the best-performing ETFs so far in 2024.
Ask a question